Form 4: Hims & Hers Director Delos Cosgrove Acquires Over 9,900 Shares Through RSU Vesting
Insider Transaction Report
Delos M. Cosgrove, a Director at Hims & Hers Health, Inc., acquired 9,935 shares of Class A Common Stock on June 12, 2025, through the vesting of Restricted Stock Units, increasing his total beneficial ownership to 64,339 shares.
Summary
- Delos M. Cosgrove, a Director of Hims & Hers Health, Inc. (HIMS), acquired 9,935 shares of Class A Common Stock.
- The acquisition occurred on June 12, 2025, through the exercise or conversion of Restricted Stock Units (RSUs).
- Following this transaction, Mr. Cosgrove's direct beneficial ownership of Class A Common Stock increased to 64,339 shares.
- The RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU.
- These RSUs were subject to continuous service and were set to vest on the earlier of the 2025 annual meeting of stockholders or June 15, 2025.
Sentiment
Score: 7
Explanation: The sentiment is positive as a director's acquisition of shares, even through vesting, increases their stake and aligns their interests with shareholders, indicating confidence in the company.
Positives
- The acquisition of shares by a director through RSU vesting indicates a standard compensation event and increases the director's direct stake in the company, aligning their interests with those of shareholders.
- The increase in beneficial ownership by a director can be viewed as a positive signal of confidence in the company's future prospects.
Future Outlook
The filing indicates that the Restricted Stock Units were subject to vesting on the earlier of the 2025 annual meeting of stockholders or June 15, 2025, suggesting a pre-determined schedule for equity compensation.
Industry Context
This Form 4 filing is a routine disclosure of an insider transaction, common across publicly traded companies, reflecting the vesting of equity compensation for a director. Such transactions are part of standard corporate governance and compensation practices aimed at aligning management and director interests with shareholders.
Related Party Transactions
- The acquisition of shares by Director Delos M. Cosgrove through the vesting of Restricted Stock Units represents a standard equity compensation transaction between the company and a related party (director).
Stakeholder Impact
- Shareholders: The increase in a director's beneficial ownership through equity vesting can be seen as a positive signal, indicating alignment of interests and confidence in the company's long-term performance.
- Employees: The transaction is part of a standard equity compensation framework, which is a common practice in publicly traded companies to incentivize and retain key personnel.
Next Steps
- The acquired shares are now part of the director's beneficial ownership, subject to standard trading rules and future disclosure requirements for any subsequent transactions.
Key Dates
| Date | Description |
|---|---|
| 06/12/2025 | Date of transaction: Acquisition of 9,935 Class A Common Stock shares upon RSU vesting. |
| 06/15/2025 | Potential vesting date for Restricted Stock Units (RSUs), if earlier than the 2025 annual meeting of stockholders. |
| 06/16/2025 | Date the Form 4 filing was signed by the attorney-in-fact for the reporting person. |
| 2025 Annual Meeting | Potential vesting date for Restricted Stock Units (RSUs), if earlier than June 15, 2025. |
Keywords
Hims & Hers Health Inc., HIMS, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Director Stock Acquisition, Beneficial Ownership, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.